Drilon, A.
476  results:
Search for persons X
?
4

EP10.01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET An..:

Drilon, A. ; Awad, M.M. ; Camidge, D.R....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S602-S603 , 2023
 
?
5

15MO Efficacy and ctDNA analysis in an updated cohort of pa..:

Hoejgaard, M. ; Drilon, A. ; Lin, J.J....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S48-S49 , 2023
 
?
 
?
7

OA19.05 Activating MET Tyrosine Kinase Domain Mutations as ..:

Nakazawa, S. ; Pecci, F. ; Ricciuti, B....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S88-S89 , 2023
 
?
10

OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive..:

Cho, B.C. ; Camidge, D.R. ; Lin, J.J....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S50-S51 , 2023
 
?
11

MA06.08 Real-World Landscape Analysis of Activating ERBB2/E..:

Liu, D. ; Jee, J. ; Keller, R.B....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S120-S121 , 2023
 
?
13

81TiP NVL-655, a selective anaplastic lymphoma kinase (ALK)..:

Johnson, M.L. ; Ou, S-H.I. ; Felip, E....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S86-S87 , 2023
 
?
14

CNS Outcomes in ALK Fusion Positive NSCLC Patients with BM ..:

Miao, E. ; Lebow, E.S. ; Eichholz, J....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e59-e60 , 2022
 
?
15

EP08.02-148 Extended Follow-up of Efficacy and Safety of La..:

Moreno, V. ; Lin, J.J. ; Tan, D.S.W....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S473-S474 , 2022
 
1-15